We believe in ImmUnity for all.
AlloVir is the global leader in developing virus-specific T cell (VST) immunotherapies. We are united in a shared vision to defeat viral diseases. We champion scientific excellence and rigor and challenge each other and the status quo as we work toward restoring hope for immunocompromised patients.
Join us in pioneering science and defeating viral diseases.
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?